These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7075860)

  • 21. Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia.
    Sava G; Giraldi T; Bartoli-Klugmann F; Decorti G; Mallardi F
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):287-9. PubMed ID: 6538492
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological evaluation of combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; Wallace TL; Hamilton RD; DeKoning TF
    Int J Immunopharmacol; 1987; 9(1):31-9. PubMed ID: 3583503
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leukaemia and P815 mast cell leukaemia.
    Chitnis MP; Adwankar MK; Amonkar AJ
    J Cancer Res Clin Oncol; 1985; 109(3):208-9. PubMed ID: 4008516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effect of implanted ethylene-vinyl alcohol copolymer matrices containing anticancer agents on Ehrlich ascites carcinoma and P388 leukemia in mice.
    Miyazaki S; Takeuchi S; Hou WM; Hashiguchi N; Yokouchi C; Takada M; Hosokawa M; Koga Y; Kobayashi H
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2490-8. PubMed ID: 4064208
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of megadose vitamin therapy in an experimental brain tumor.
    Newell SD; Kapp J; Romfh JH
    Surg Neurol; 1981 Aug; 16(2):161-4. PubMed ID: 7280989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ascorbic acid and adriamycin toxicity.
    Shimpo K; Nagatsu T; Yamada K; Sato T; Niimi H; Shamoto M; Takeuchi T; Umezawa H; Fujita K
    Am J Clin Nutr; 1991 Dec; 54(6 Suppl):1298S-1301S. PubMed ID: 1962586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of antitumor activity of ORG 5895, a 11 beta-aziridinylmethyl derivative of estradiol, on the MXT mammary tumor and the P388 leukemia.
    Devleeschouwer N; Leclercq G; Danguy A; Atassi G
    Cancer Chemother Pharmacol; 1982; 8(3):315-6. PubMed ID: 7127663
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
    Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of concomitant infusion of thymidine and inosine on methotrexate activity in normal and P388-bearing mice.
    Uitendaal MP; Schornagel JH; Leyva A; Pinedo HM
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1527-32. PubMed ID: 6542016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trichothecene analogues. 1. 1,5-Dioxaspiro(2.5)octanes.
    Fullerton DS; Chen CM; Hall IH
    J Med Chem; 1976 Dec; 19(12):1391-5. PubMed ID: 1003423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of CSD and it's antitumor effect].
    Chen ZZ
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):251-3. PubMed ID: 2625104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    J Pharmacobiodyn; 1983 Feb; 6(2):145-7. PubMed ID: 6864439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effect of avermectins.
    Drinyaev VA; Mosin VA; Kruglyak EB; Novik TS; Sterlina TS; Ermakova NV; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
    Eur J Pharmacol; 2004 Oct; 501(1-3):19-23. PubMed ID: 15464058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice.
    Tsuruo T; Naganuma K; Iida H; Yamori T; Tsukagoshi S; Sakurai Y
    J Antibiot (Tokyo); 1981 Sep; 34(9):1206-9. PubMed ID: 7328059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.
    Plunkett W
    Ann N Y Acad Sci; 1985; 451():150-9. PubMed ID: 3907452
    [No Abstract]   [Full Text] [Related]  

  • 36. Anticancer activity of zoanthids and the associated toxin, palytoxin, against Ehrlich ascites tumor and P-388 lymphocytic leukemia in mice.
    Quinn RJ; Kashiwagi M; Moore RE; Norton TR
    J Pharm Sci; 1974 Feb; 63(2):257-60. PubMed ID: 4149775
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy of P388 leukemia with benzaldehyde.
    Balázová E; Koza I
    Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS; Chitnis MP
    Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R; Grabowski D
    Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Johnson RK; Howard WS
    Eur J Cancer Clin Oncol; 1982 May; 18(5):479-87. PubMed ID: 6956514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.